Theralase Provides Bladder Cancer Clinical Study Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| ISHARES 20+ YEAR TREASURY BOND ETF (NASDAQ: TLT) | Delayed: 81.68 +0.34 (0.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $81.34 | 52 Week High | $143.62 | |||
| Open | $81.66 | 52 Week Low | $118.66 | |||
| Day High | $81.90 | P/E | N/A | |||
| Day Low | $81.54 | EPS | $0.00 | |||
| Volume | 24,527,895 | |||||
| Theralase Technologies Inc Ordinary Share (AMEX: TLTFF) | Delayed: 0.14 -0.01 (6.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.15 | 52 Week High | $0.35 | |||
| Open | $0.14 | 52 Week Low | $0.18 | |||
| Day High | $0.15 | P/E | N/A | |||
| Day Low | $0.14 | EPS | $0.00 | |||
| Volume | 29,760 | |||||
